Blood clues may reveal best candidates for Parkinson's brain surgery

NCT ID NCT07376278

First seen Feb 01, 2026 · Last updated May 24, 2026 · Updated 15 times

Summary

This study aims to find proteins and genetic material in the blood that can predict how well a person with Parkinson's disease will respond to deep brain stimulation (DBS) surgery. Researchers will collect blood and leftover brain tissue from 30 participants undergoing DBS, and track their symptoms over time. The goal is to better understand why some people improve more than others, which could help doctors choose the best candidates for this treatment in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEEP BRAIN STIMULATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Hong Kong University of Science and Technology

    RECRUITING

    Hong Kong, Hong Kong

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.